Veracyte Inc (VCYT NASDAQ) stock market data APIs
$27.2118
-0.02(-0.1%)
as of July 11, 2025
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
27.2118
Open
27.1885
High
27.9432
Low
26.9148
52 wk Range
19.73-47.3162
Market Cap
2 121 M
P/E Ratio
64.4762
Shares Outstanding
78 315 K
Revenue
463 M
EPS
0.31
Beta
2.095
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 463 M
- EBITDA: 62 280 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-05
- EPS/Forecast: -0.17
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025
SOUTH SAN FRANCISCO, Calif., July 08, 2025--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented ...
Veracyte Q3 2024 slides: Revenue surges 29%, guidance raised for third time
Introduction & Market Context Veracyte Inc (NASDAQ:VCYT) presented its third quarter 2024 business and financial results on November 6, 2024, showcasing exceptional performance with 29% year-over-ye...
Cathie Wood's ARK ETFs shuffle healthcare and tech stock holdings
Cathie Wood’s ARK ETFs have made their daily trades for Wednesday, June 25th, 2025, with a significant focus on healthcare and technology stocks. The trades included both substantial acquisitions an...
Cathie Wood's ARK ETF trades Shopify, Toast stock amid tech focus
Cathie Wood’s ARK ETFs have revealed their daily trades for Tuesday, June 24th, 2025, with notable activity in the technology sector. ARK’s most significant trades of the day included purchases of...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
